. Author manuscript; available in PMC: 2018 Jun 1.

Published in final edited form as: Adv Mater. 2017 Mar 29;29(23):10.1002/adma.201606857. doi: 10.1002/adma.201606857

Table 4.

ROS-driven turn on theranostics.

ROS	Bioactive link/group	Signal reporter	Therapeutic agent	Imaging modality	Therapeutic modality	Ref.
H₂O₂	Boronate	SN-38	SN-38	FLI	CHT	146
H₂O₂	Phenylboronic ester	QCy7	Camptothecin	FLI	CHT	147
H₂O₂	arylboronate ester	FITC/Gd	DOX	FLI/MRI	CHT	148
H₂O₂	MnO₂	UCSMs	MnO₂	UCLI/PAI	RT/PDT	149
H₂O₂	Fe³⁺	Fe³⁺	Methylene blue	MRI	PDT	150
H₂O₂	HPOX	Rubrene	HPOX	FLI	Antioxidant	151
ONOO⁻	Hyaluronic acid	Ce6	Ce6	FLI	PDT	152
ROS	Thioketal	Ce6	CPT/Ce6	FLI	CHT/PDT	153
¹O₂	Aminoacrylate	AIEgen/Rho	AIEgen	FLI	PDT	154